Global Glucosamine Market, By Type (Glucosamine Hydrochloride, Glucosamine Sulfate Potassium Chloride, Glucosamine Sulfate Sodium Chloride, N-acetyl Glucosamine), Dosage (Powder, Tablets, Capsule, Liquid), Route of Administration (Topical, Intramuscular, Oral), Application (Rheumatoid Arthritis, Asthma, Diabetes, High cholesterol, Osteoarthritis, Inflammatory Bowel Disease, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Industry Trends and Forecast to 2030.
Glucosamine Market Analysis and Size
Rise in the prevalence of rheumatoid arthritis, advancement in treatment options, and rising awareness are the factors that will expand the global glucosamine market. The development of vegetarian glucosamine is critical when many individuals are converting to a vegan diet to live a healthier lifestyle as it’s a vegetarian-friendly formula, vegetarian glucosamine is one of the safest vegetarian joint supplements. Moreover, rising R&D activities, ongoing clinical trials, and emerging markets will further create new opportunities for the glucosamine market in the forecast period.
Data Bridge Market Research analyses that the glucosamine market which was USD 581.60 million in 2022, will reach USD 923.01 million by 2030, and is expected to grow a CAGR of 6.1% during the forecast period of 2023 to 2030. “Hospitals” dominates the end user segment of the glucosamine market owing to the growing demand. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Glucosamine Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Type (Glucosamine Hydrochloride, Glucosamine Sulfate Potassium Chloride, Glucosamine Sulfate Sodium Chloride, N-acetyl Glucosamine), Dosage (Powder, Tablets, Capsule, Liquid), Route of Administration (Topical, Intramuscular, Oral), Application (Rheumatoid Arthritis, Asthma, Diabetes, High cholesterol, Osteoarthritis, Inflammatory Bowel Disease, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Bio-gen Extracts Private Limited (India), Panvo Organics Pvt Ltd (India), Pharma Base S.A. (Switzerland), CAPTEK Softgel International Inc. (U.S.), TSI GROUP LTD (Australia), Cargill, Incorporated (U.S.), CELLMARK AB. (Sweden), Zhejiang Zhoushan Putuo Xinxing Pharmas Co. Ltd. (PXPC) (China), Andra Medi Pharma Pvt. Ltd (India), Jiaxing Hengjie Biopharmaceutical Co., Ltd. (China), Spectrum Chemical Manufacturing Corp. (U.S.), RB Health LLC (U.S.), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), among other
|
|
Market Opportunities
|
|
Market Definition
Glucosamine is a natural compound found in cartilage and made from fructose and the amino acid glutamine. It is important for the production of glycosaminoglycan, which is a molecule used in the formation and repair of cartilage and other body tissues. In supplement form, glucosamine is an amino sugar that is produced by the hydrolysis of shellfish or manufactured in labs by the fermentation process of grains such as wheat and corn.
Global Glucosamine Market Dynamics
Drivers
- Increasing prevalence of osteoarthritis
Rising prevalence of osteoarthritis attribute to the increased adoption of the drug for the treatment of disease across the globe. People are now increasingly adopting the therapy for the treatment as they are more convenient, effective. Growing cases of arthritis around the world are raising awareness about the benefits of glucosamine, is propelling the growth of the market. Arthritis affects almost 54 million people in the United States. As shown in a Centre for Disease Control and Prevention analysis, the proportion of the population with arthritis is already on the rise, with over 78 million predicted by 2040. This obesity is also known to be a factor helping the penetration of glucosamine in the world. Over 1.9 billion people over the age of eighteen were overweight in 2016. If glucosamine is used in one's diet, it can support them lose weight while also improving joint stability.
The World Health Organization (WHO) estimates that between 10% to 15% of the population aged 60 years and above have some form of osteoarthritis. Also, the awareness level of the general population towards health and wellness supplements, especially those used for bone and joint health is high. These factors are increasingly driving the market.
- Increased usage of bone and joint health supplements
Maintaining a healthy lifestyle and preventing bone diseases is making consumers pay premium prices for glucosamine supplements, as they impart health benefits, targeting treatment of a specific segment of the human body. The essential properties of glucosamine have encouraged the manufacturers to introduce new products and, thus, lead to the overall growth of the glucosamine market.
The World Health Organization (WHO) has estimated that almost 22 million individuals in Europe and 14 million in the United States alone will be suffering from osteoporosis.
- Rising number of geriatric population
Expanding geriatric population worldwide is predicted to favour glucosamine demand as this population is more prone to chronic diseases. The number of persons above 65 years is projected to double in the coming years. Old age people are prone to various chronic diseases which can foster the demand for glucosamine across the globe.
Bone and Joint Health Supplements target the aging population and the percentage of population above the age of 65 is significantly high in regions such as North America and Europe.
According to the United Nations, there were around 382 million old age people, aged 60 years or above, across the globe in 2017 and this number is expected 2.1 billion by 2050.
Opportunity
- Rise in government funds and support.
Furthermore, an increase in government funds and support for target research activities, rising clinical trials and rising product innovations and development owing to technological advancements all around the world will extend profitable opportunities for the market players in the forecast period of 2023 to 2030.The demand for specialized treatment is projected to drive the glucosamine market growth. These developments are anticipated to expedite the market expansion for glucosamine in the future.
Restrain/Challenge
- High cost of products
On the other hand, high cost of products is expected to restrain the market. The special manufacturing processes can make these molecules more absorbable. Naturally, that special processing costs money, making the “good quality”, readily absorbed, products more expensive to purchase. The various side effects of glucosamine such as heartburn, drowsiness, and headache are the factors that will hamper the global glucosamine market growth. Moreover, volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will further challenge the glucosamine market in the forecast period of 2023-2030.
This glucosamine market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the glucosamine market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In 2021, Nestle China launched its first set of ‘blue-hat’ certified health foods for seniors – a milk powder containing glucosamine and a probiotic protein powder. This results in expanding the product portfolio of the company.
Global Glucosamine Market Scope
The glucosamine market is segmented on the basis of type, dosage, route of administration, application, end-users, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Glucosamine Hydrochloride
- Glucosamine Sulfate Potassium Chloride
- Glucosamine Sulfate Sodium Chloride
- N-acetyl Glucosamine
Dosage
- Powder
- Tablets
- Capsule
- Liquid
Route of Administration
- Topical
- Intramuscular
- Oral
Application
- Rheumatoid Arthritis
- Asthma, Diabetes
- High cholesterol
- Osteoarthritis
- Inflammatory Bowel Disease
- Others
End-User
- Hospitals
- Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Global Glucosamine Market Regional Analysis/Insights
The global glucosamine market is analyzed and market size insights and trends are provided by country, type, dosage, route of administration, application, end-users and distribution channel as referenced above.
The countries covered in the glucosamine market report are the U.S., Canada, and Mexico in North America, Germany, France, the U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the glucosamine market due to the presence of major key players, continuous technological development, a well-developed healthcare sector, increasing prevalence of disease and increasing awareness towards health in this region.
Asia-Pacific is expected to grow at the highest growth rate during the forecast period of 2023 to 2030 due to increasing research and development activities, emerging markets, rising investment in the healthcare sector, and growing government support in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The glucosamine market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for glucosamine market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the glucosamine market. The data is available for historic period 2010-2021.
Competitive Landscape and Glucosamine market Share Analysis
The glucosamine market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to glucosamine market.
Some of the major players operating in the glucosamine market are:
- Spectrum Chemical Manufacturing Corp. (U.S.)
- RB Health LLC (U.S.)
- Mylan N.V. (U.S.)
- CAPTEK Softgel International Inc. (U.S.)
- TSI GROUP LTD (Australia)
- Cargill, Incorporated (U.S.)
- Teva Pharmaceutical Industries Ltd.(Israel)
- Bio-gen Extracts Private Limited (India)
- Panvo Organics Pvt Ltd (India)
- Pharma Base S.A. (Switzerland)
- CELLMARK AB. (Sweden)
- Zhejiang Zhoushan Putuo Xinxing Pharmas Co. Ltd. (PXPC) (China)
- Andra Medi Pharma Pvt. Ltd (India)
- Jiaxing Hengjie Biopharmaceutical Co., Ltd. (China)
SKU-